A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescent (12 to less than 18 Years) and Adult Subjects With Intermittent or Mild to Moderate Persistent Asthma.

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled, Single-Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescent (12 to less than 18 Years) and Adult Subjects With Intermittent or Mild to Moderate Persistent Asthma.

Withdrawn prior to enrolment
Phase of Trial: Phase I

Latest Information Update: 24 Nov 2013

At a glance

  • Drugs Brodalumab (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Sponsors Amgen
  • Most Recent Events

    • 18 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top